Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: Structural and functional analysis

Progress in Neurobiology

Volumn 90, Issue 2, 2010, Pages 198-216

  de la Mora, Miguel Pérez ^a   Gallegos Cari, Andrea ^a   Arizmendi García, Yexel ^a   Marcellino, Daniel ^b   Fuxe, Kjell ^b  

^a INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Amygdala; Anxiety; D1 receptor; D2 receptor; DA mapping

Indexed keywords

4 AMINOBUTYRIC ACID; CYCLIC AMP; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE AUTORECEPTOR; DOPAMINE RECEPTOR; MESSENGER RNA; NEUROTRANSMITTER;

AMYGDALOID NUCLEUS; ANXIETY; BINDING AFFINITY; BRAIN CORTEX; CLASSIFICATION; COPING BEHAVIOR; DNA MODIFICATION; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; FEAR; FOREBRAIN; FUNCTIONAL ASSESSMENT; GABAERGIC SYSTEM; HUMAN; INNERVATION; INTERNEURON; NEUROANATOMY; NEUROBIOLOGY; NEUROCHEMISTRY; NEUROMODULATION; NONHUMAN; OLIVARY NUCLEUS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; SOMATOSENSORY SYSTEM; STRUCTURE ANALYSIS; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION; TRANSGENIC ANIMAL;

AMYGDALA; ANIMALS; ANXIETY; DISEASE MODELS, ANIMAL; DOPAMINE AGENTS; FEAR; HUMANS; RECEPTORS, DOPAMINE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 76849107698     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2009.10.010     Document Type: Review

References (298)

1. Abercrombie E.D., Keefe K.A., DiFrischia D.S., and Zigmond M.J. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J. Neurochem. 52 (1989) 1655-1658
2. Aggleton J.P., Burton M.J., and Passingham R.E. Cortical and subcortical afferents to the amygdala of the rhesus monkey (Macaca mulatta). Brain Res. 190 (1980) 347-368
3. Aghajanian G.K., and Bunney B.S. Dopamine "autoreceptors". Pharmacological characterization by microiontophoretic single cell recording studies. Naunyn Schmiedebergs Arch. Pharmac. 297 (1977) 1-7
4. Agnati L.F., Ferré S., Lluis C., Franco R., and Fuxe K. Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol. Rev. 55 (2003) 509-550
5. Agnati L.F., Guidolin D., Leo G., and Fuxe K. A Boolean network modelling of receptor mosaics relevance of topology and cooperativity. J. Neural Transm. 114 (2007) 77-92
6. Agnati L.F., Fuxe K.G., Goncharova L.B., and Tarakanov A.O. Receptor mosaics of neural and immune communication: possible implications for basal ganglia functions. Brain Res. Rev. 58 (2008) 400-414
7. Alheid G.F., and Heimer L. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience 2 (1988) 1-39
8. Amaral D.G., Price J.L., Pitkännen A., and Carmichael S.T. Anatomical organization of the primate amygdaloid complex. In: Aggleton J.P. (Ed). The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction (1992), Wiley-Liss, Inc., New York 1-66
9. Andén N.E., Carlsson A., Dahlström A., Fuxe K., Hillarp N.-A., and Larsson K. Demonstration and mapping out of nigro-neostriatal dopamine neurons. Life Sci. 3 (1964) 523-530
10. Anden N.E., Dahlström A., Fuxe K., and Larsson K. Mapping out of catecholamine and 5-hydroxytryptamine neurons innervating the telencephalon and diencephalon. Life Sci. 4 (1965) 1275-1279
11. Anden N.E., Dahlström A., Fuxe K., Larsson K., Olson L., and Ungerstedt U. Ascending monoamine neurons to the telencephalon and diencephalon. Acta Physiol. Scand. 67 (1966) 313-326
12. Andersen P.H. Comparison of the pharmacological characteristics of [3H] raclopride and SCH23390 binding to dopaminereceptors in vivo in mouse brain. Eur. J. Pharmacol. 146 (1988) 113-120
13. Arnt J., Hyttel J., and Sanchez C. Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro. Eur. J. Pharmacol. 213 (1992) 259-267
14. Asan E. Comparative single and double immunolabelling with antisera against catecholamine biosynthetic enzymes: criteria for the identification of dopaminergic, noradrenergic and adrenergic structures in selected rat brain areas. Histochemistry 99 (1993) 427-442
15. Asan E. Ultrastructural features of tyrosine-hydroxylase-immunoreactive afferents and their targets in the rat amygdala. Cell Tissue Res. 288 (1997) 449-469
16. Ashford J., and Jones B.J. The effects of intra-amygdaloid injections of 6-hydroxy-dopamine on avoidance responding in rats. Br. J. Pharmacol. 56 (1976) 255-261
17. Bahar A., Samuel A., Hazvi S., and Dudai Y. The amygdalar circuit that acquires taste aversion memory differs from the circuit that extinguishes it. Eur. J. Neurosci. 17 (2003) 1527-1530
18. Bandler R., Price J.L., and Keay K. Brain mediation of active and passive emotional coping. Prog. Brain Res. 107 (2000) 285-300
19. Bannon M.J., Michaud R.L., and Roth R.H. Mesocortical dopamine neurons: lack of autoreceptors modulating dopamine synthesis. Mol. Pharmacol. 19 (1981) 270-275
20. Bannon M.J., Reinhard Jr. J.R., Bunney E.B., and Roth R.H. Unique response to antipsychotic drugs is due to absence of terminal autoreceptors in mesocortical dopamine neurones. Nature 296 (1982) 444-446
21. Basso A.M., Spina M., River J., Vale W., and Koob G.F. Corticotropin-releasing factor antagonists attenuates the 'anxiogenic-like effect' in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology 145 (1999) 21-30
22. Beckstead R.M., Domesick V.B., and Nauta W.J. Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res. 175 (1979) 171-217
23. Belzung C., and Le Pape G. Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety. Physiol. Behav. 56 (1994) 623-628
24. Bernard J.F., and Besson J.M. Convergence of nociceptive information on the parabrachio-amygdala neurons in the rat. C. R. Acad. Sci. III 307 (1988) 841-847
25. Bernard J.F., Huang G.F., and Besson J.M. Nucleus centralis of the amygdala and the globus pallidus ventralis: electrophysiological evidence for an involvement in pain processes. J. Neurophysiol. 68 (1992) 551-569
26. Bissiere S., Humeau Y., and Luthi A. Dopamine gates LTP induction in lateral amygdala by suppressing feedforward inhibition. Nat. Neurosci. 6 (2003) 587-592
27. Björklund A., and Lindvall O. Dopamine-containing systems in the CNS. Classical transmitters in the CNS. In: Björklund A., and Lindvall O. (Eds). Handbook of Chemical Neuroanatomy (1984), Elsevier, Amsterdam 55-122
28. Blackburn J.R., Pfaus J.G., and Phillips A.G. Dopamine functions in appetitive and defensive behaviours. Prog. Neurobiol. 39 (1992) 247-279
29. Blair H.T., Schaffe G.F., Bauer E.P., Rodrigues S.M., and Le Doux J.E. Synaptic plasticity in the lateral amygdala: a cellular hypothesis of fear conditioning. Learn. Mem. 8 (2001) 229-242
30. Blanchard R.J., and Blanchard D.C. Passive and active reactions to fear eliciting stimuli. J. Comp. Physiol. Psychol. 68 (1969) 129-135
31. Blanchard R.J., and Blanchard D.C. Anti-predator defensive behaviors in a visible burrow system. J. Comp. Physiol. Psychol. 103 (1989) 70-82
32. Blanchard R.J., Blanchard D.C., Takahashi T., and Kelly M.J. Attack and defensive behavior in the albino rat. Anim. Behav. 75 (1977) 622-634
33. Blanchard D.C., Rodgers R.J., Hori K., Hendrie C.A., and Blanchard R.J. Attenuation of defensive threat and attack in wild rats (Rattus rattuss) by benzodiazepines. Psychopharmacology 97 (1989) 392-401
34. Blanchard D.C., Blanchard R.J., and Rodgers R.J. Pharmacological and neural control of anti-predator defense in the rat. Aggress. Behav. 16 (1990) 165-175
35. Blanchard R.J., Yudko E.B., Rodgers R.J., and Blanchard D.C. Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety. Behav. Brain Res. 58 (1993) 155-165
36. Bliss T.V.P., and Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J. Physiol. 232 (1973) 331-356
37. Bliss T.V., and Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361 (1993) 31-39
38. Bolles R.C. Species-specific defense reactions and avoidance learning. Psychol. Rev. 77 (1970) 32-48
39. Borowski T.B., and Kokkinidis L. Contribution of ventral tegmental area dopamine neurons to expression of conditional fear: effects of electrical stimulation, excitotoxin lesions, and quinpirole infusion on potentiated startle in rats. Behav. Neurosci. 110 (1996) 1349-1364
40. 125I]iodosulpride. Neuroscience 20 (1987) 117-155
41. Boyson S.J., McGonigle P., and Molinoff P.B. Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J. Neurosci. 6 (1986) 3177-3188
42. Brinley-Reed M., and McDonald A.J. Evidence that dopaminergic axons provide a dense innervations of specific neuronal subpopulations in the rat basolateral amygdala. Brain Res. 850 (1999) 127-135
43. Bouthenet M.L., Souil M., Martres M.P., Sokoloff P., Giros B., and Schwartz J.C. Localization of dopamine D3 receptor mRNA mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res. 564 (1991) 203-219
44. Bristow L.J., Collinson N., Cook G.P., Curtis N., Freedman S.B., Kulagowski J.J., Leeson P.D., Patel S., Ragan C.I., Ridgill M., Saywell K.L., and Tricklebank M.D. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests. J. Pharmacol. Exp. Ther. 283 (1997) 1256-1263
45. Broekkamp C.L., Berendsen H.H., Jenck F., and Van Delft A.M. Animal models for anxiety and response to serotonergic drugs. Psychopathology 22 Suppl. 1 (1989) 2-12
46. Browman K.E., Curzon P., Pan J.B., Molesky A.L., Komater V.A., Decker M.W., Brioni J.D., Moreland R.B., and Fox G.B. A-412997, a selective dopamine D4 agonist, improves cognitive performance in rats. Pharmacol. Biochem. Behav. 82 (2005) 148-155
47. Bull D.R., Bakhtiar R., and Sheehan M.J. Characterization of dopamine autoreceptors in the amygdala: a fast cyclic voltammetric study in vitro. Neurosci. Lett. 134 (1991) 41-44
48. Burstein R., and Potrebic S. Retrograde labeling of neurons in the spinal cord that project directly to the amygdala or the orbital cortex in the rat. J. Comp. Neurol. 335 (1993) 469-485
49. Camacho-Ochoa M., Walker E.L., Evans D.L., and Piercey M.F. Rat brain binding sites for pramipexole, a clinically useful D3-preferring dopamine agonist. Neurosci. Lett. 196 (1995) 97-100
50. Camps M., Cortés R., Gueye B., Probst A., and Palacios J.M. Dopamine receptors in human brain: autoradiographic distribution of D2 sites. Neuroscience 28 (1989) 275-290
51. Carter D.A., and Fibiger H.C. Ascending projections of presumed dopamine-containing neurons in the ventral tegmentum of the rat as demonstrated by horseradish peroxidase. Neuroscience 2 (1977) 569-576
52. Cassell M.D., Gray T.S., and Kiss J.Z. Neuronal architecture in the rat central nucleus of the amygdala: a cytological, hodological, and immunocytochemical study. J. Comp. Neurol. 246 (1986) 478-499
53. Chapman P.F., Kairiss E.W., Keenan C.L., and Brown T.H. Long-term synaptic potentiation in the amygdala. Synapse 6 (1990) 271-278
54. Clugnet M.C., and LeDoux J.E. Synaptic plasticity in fear conditioning circuits: induction of LTP in the lateral nucleus of the amygdala by stimulation of the medial geniculate body. J. Neurosci. 10 (1990) 2818-2824
55. Coco M.L., Kuhn C.M., Ely T.D., and Kilts C.D. Selective activation of mesoamygdaloid dopamine neurons by conditioned stress: attenuation by diazepam. Brain Res. 590 (1992) 39-47
56. Coffeen U., López-Avila A., Ortega-Legaspi J.M., del Angel R., López-Muñoz F.J., and Pellicer F. Dopamine receptors in the anterior insular cortex modulate long-term nociception in the rat. Eur. J. Pain 12 (2008) 535-543
57. Corbit L.H., and Balleine B.W. Double dissociation of basolateral and central amygdala lesions on the general and outcome-specific forms of pavlovian-instrumental transfer. J. Neurosci. 25 (2005) 962-970
58. Cortés R., Gueye B., Pazos A., Probst A., and Palacios J.M. Dopamine receptors in human brain: autoradiographic distribution of D1 sites. Neuroscience 28 (1989) 263-273
59. Dahlström A., and Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. 62 Suppl. 232 (1964) 1-55
60. Davidson R.J. Anxiety and affective style: role of prefrontal cortex and amygdala. Biol. Psychiatry 51 (2002) 68-80
61. Davis M. The role of the amygdala in fear-potentiated startle: implications for animal models of anxiety. Trends Pharmacol. Sci. 13 (1992) 35-41
62. Davis M. The role of the amygdala in conditioned fear. In: Aggleton J.P. (Ed). The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction (1992), Wiley-Liss, Inc., New York 255-305
63. Davis M., Falls W.A., Campeau S., and Kim M. Fear-potentiated startle: a neural and pharmacological analysis. Behav. Brain Res. 58 (1993) 175-198
64. Davis M., and Whalen P.J. The amygdala: vigilance and emotion. Mol. Psychiatry 6 (2001) 13-34
65. Davis M., Walker D.L., and Myers K.M. Role of the amygdala in fear extinction measured with potentiated startle. Ann. N.Y. Acad. Sci. 985 (2003) 218-232
66. Dawson T.M., Gehlert D.R., McCabe R.T., Barnett A., and Wamsley J.K. D-1 dopamine receptors in the rat brain: a quantitative autoradiographic analysis. J. Neurosci. 6 (1986) 2352-2365
67. Dawson T.M., Barone P., Sidhu A., Wamsley J.K., and Chase T.N. The D1 dopamine receptor in the rat brain: quantitative autoradiographic localization using an iodinated ligand. Neuroscience 26 (1988) 83-100
68. De Boer S.F., and Koolhaas J.M. Defensive burying in rodents: ethology, neurobiology and psychopharmacology. Eur. J. Pharmacol. 463 (2003) 145-161
69. De Keyser J., Walraevens H., Ebinger G., and Vauquelin G. In human brain two subtypes of D1 dopamine receptors can be distinguished on the basis of differences in guanine nucleotide effect on agonist binding. J. Neurochem. 53 (1989) 1096-1102
70. Deniau J.M., Thierry A.M., and Feger J. Electrophysiological identification of mesencephalic ventromedial tegmental (VMT) neurons projecting to the frontal cortex, septum and nucleus accumbens. Brain Res. 189 (1980) 315-326
71. DeOlmos J.S. Amygdala. In: Paxinos G. (Ed). The Human Nervous System (1990), Academic Press, Sydney, Australia 583-710
72. Deutch A.Y., Tam S.Y., and Roth R.H. Footshock and conditioned stress increase 3,4-dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not substantia nigra. Brain Res. 333 (1985) 143-146
73. Deutch A.Y., Goldstein M., Baldino Jr. F., and Roth R.H. Telencephalic projections of the A8 dopamine cell group. Ann. N.Y. Acad. Sci. 537 (1988) 27-50
74. Drago J., Gerfen C.R., Lachowicz J.E., Steiner H., Hollon T.R., Love P.E., Ooi G.T., Drago J., Padungchaichot P., Accili D., and Fuchs S. Dopamine receptors and dopamine transporter in brain function and addictive behaviors: insights from targeted mouse mutants. Dev. Neurosci. 20 (1998) 188-203
75. 3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors. Neuroscience 19 (1986) 125-137
76. El-Ghundi M., O'Dowd B.F., and George S.R. Insights into the role of dopamine receptor systems in learning and memory. Rev. Neurosci. 18 (2001) 37-66
77. Emson P.C., and Lindvall O. Distribution of putative neurotransmitters in the neocortex. Neuroscience 4 (1979) 1-30
78. Engin E., and Treit D. The anxiolytic-like effects of allopregnanolone vary as a function of intracerebral microinfusion site: the amygdala, medial prefrontal cortex, or hippocampus. Behav. Pharmacol. 18 (2007) 461-470
79. Engin E., and Treit D. The effects of intra-cerebral drug infusions on animals' unconditioned fear reactions: a systematic review. Prog. Neuro-Psychopharmacol. Biol. Psychol. 32 (2008) 1399-1419
80. Esclapez M., Tillakaratne N.J., Tobin A.J., and Houser C.R. Comparative localization of mRNAs encoding two forms of glutamic acid decarboxylase with nonradioactive in situ hybridization methods. J. Comp. Neurol. 331 (1993) 339-362
81. Everitt B.J., Cardinal R.N., Parkinson J.A., and Robbins T.W. Appetitive behavior. Impact of amygdala-dependent mechanisms of emotional learning. Ann. N.Y. Acad. Sci. 985 (2003) 233-250
82. Falck B., Hillarp N.-A., Thieme G., and Torp A. Fluorescence of catecholamines and related compounds condensed with formaldehyde. J. Histochem. Cytochem. 10 (1962) 348-354
83. Fallon J.H. Histochemical characterization of dopaminergic, noradrenergic and serotonergic projections to the amygdala. In: Ben-Ari Y. (Ed). The Amygdaloid Complex (1981), Elsevier, Amsterdam 175-183
84. Fallon J.H. Topographic association of ascending dopaminergic projections. Ann. N.Y. Acad. Sci. 537 (1988) 1-9
85. Fallon J.H., and Moore R.Y. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J. Comp. Neurol. 180 (1978) 545-580
86. Fallon J.H., and Ciofi P. Distribution of monoamines within the amygdala. In: Aggleton J.P. (Ed). The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction (1992), Wiley-Liss, Inc., New York 97-114
87. Fallon J.H., and Loughlin S.E. Substantia nigra. In: Paxinos G. (Ed). The Rat Nervous System, vol. I. Forebrain and Midbrain. 2nd ed. (1995), Academic Press, Sydney, Australia 215-237
88. Fallon J.H., Koziell D.A., and Moore R. Catecholamine innervation of the basal forebrain. II. Amygdala, suprarhinal cortex and entorhinal cortex. J. Comp. Neurol. 180 (1978) 509-532
89. 3H-monoamines from field stimulated rat brain slices. Acta Physiol. Scand. Suppl. 371 (1971) 35-44
90. Feuerstein T.J. Presynaptic receptors for dopamine, histamine, and serotonin. Handbook Exp. Pharmacol. 184 (2008) 289-338
91. File S.E., and Seth P. A review of 25 years of the social interaction test. Eur. J. Pharmacol. 463 (2003) 35-53
92. Freedman L.J., and Cassell M.D. Distribution of dopaminergic fibers in the central division of the extended amygdala of the rat. Brain Res. 633 (1994) 243-252
93. Fritschy J.M., Weinmann O., Wensel A., and Benke D. Synapse-specific localization of NMDA and GABA (A) receptor subunits revealed by antigen retrieval immunohistochemistry. J. Comp. Neurol. 390 (1998) 194-210
94. Fuxe K. Evidence for the existence of monoamine neurons in the central nervous system. 3. The monoamine nerve terminal. Z. Zellforch. Mikrosk. Anat. 65 (1965) 573-596
95. Fuxe K. Evidence for the existence of monoamine neurons in the central nervous system. IV. Distribution of monoamine nerve terminals in the central nervous system. Acta Physiol. Scand. 64 Suppl. 247 (1965) 39-85
96. Fuxe K., Hökfelt T., and Ungerstedt U. Morphological and functional aspects of central monoamine neurons. Int. Rev. Neurobiol. 13 (1970) 93-126
97. Fuxe K., Jacobsen K.X., Höistad M., Tinner B., Jansson A., Staines W.A., and Agnati L.F. The dopamine D1 receptor-rich main and paracapsular intercalated nerve cell groups of the rat amygdala: relationship to the dopamine innervation. Neuroscience 119 (2003) 733-746
98. Fuxe K., Dahlström A., Höistad M., Marcellino D., Jansson A., Rivera A., Diaz-Cabiale Z., Jacobsen K., Tinner-Staines B., Hagman B., Leo G., Staines G., Guidolin G., Kehr J., Genedani S., Belluardo N., and Agnati L.F. From the Golgi-Cajal mapping to the transmitter-based characterization of the neural networks leading to two modes of brain communication: wiring and volume transmission. Brain Res. Rev. 55 (2007) 17-54
99. Fuxe K., Canals M., Torvinen M., Marcellino D., Terasmaa A., Genedani S., Leo G., Guidolin D., Diaz-Cabiale Z., Rivera A., Lundström L., Langel U., Narvaez J., Tanganelli S., Lluis C., Ferré S., Woods A., Franco R., and Agnati L.F. Intramembrane receptor-receptor interactions: a novel principle in molecular medicine. J. Neural Transm. 114 (2007) 49-75
100. Fuxe K., Marcellino D., Rivera A., Diaz-Cabiale Z., Filip M., Gago B., Roberts D.C., Langel U., Genedani S., Ferraro L., de la Calle A., Narvaez J., Tanganelli S., Woods A., and Agnati L.F. Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain Res. Rev. 58 (2008) 415-452
101. Gallager M., and Holland P.C. The amygdala complex: multiple roles in associative learning and attention. Proc. Natl. Acad. Sci. USA. 91 (1994) 11771-11776
102. Galloway M.P., Wolff M.E., and Roth R.H. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: Studies in vivo. J. Pharmacol. Exp. Ther. 236 (1986) 689-698
103. 2A receptor gene. J. Neurochem. 56 (1991) 1024-1029
104. Gauriau C., and Bernard J.-F. Pain pathways and parabrachial circuits in the rat. Exp. Physiol. 87 (2002) 251-258
105. Gingrich J.A., and Caron M.G. Recent advances in the molecular biology of dopamine receptors. Annu. Rev. Neurosci. 16 (1993) 299-321
106. Gingrich J.A., and Roder J.C. Inducible gene expression in the nervous system of transgenic mice. Annu. Rev. Neurosci. 21 (1998) 377-405
107. Goldstein M., Harada K., Meller E., Schalling M., and Hökfelt T. Dopamine autoreceptors. Biochemical, pharmacological, and morphological studies. Ann. N.Y. Acad. Sci. 604 (1990) 169-175
108. Gonzalez L.E., Andrews N., and File S.E. 5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze. Brain Res. 732 (1996) 145-153
109. Goosens K.A., and Maren S. Pretraining NMDA receptor blockade in the basolateral complex but not the central nucleus, of the amygdala prevents savings of conditional fear. Behav. Neurosci. 117 (2003) 738-750
110. Grahn R.E., Kalman B.A., Brennan F.X., Watkins L.R., and Maier S.F. The elevated plus-maze is not sensitive to the effect of stressor controllability in rats. Parmacol. Biochem. Behav. 52 (1995) 565-570
111. Gray J.A., and McNaughton N. The Neuropsychology of Anxiety: An Enquiry into the Functions of the Septo-Hippocampal system. 2nd ed. (2000), Oxford University Press, Oxford
112. Greba Q., and Kokkinidis L. Peripheral and intra-amygdalar administration of the dopamine D1 receptor antagonist SCH 23390 blocks fear-potentiated startle but not shock reactivity or the shock sensitization of acoustic startle. Behav. Neurosci. 114 (2000) 262-272
113. Greba Q., Gifkins A., and Kokkinidis L. Inhibition of amygdaloid dopamine D2 receptors impairs emotional learning measured with fear potentiated startle. Brain Res. 899 (2001) 218-226
114. Green S., and Vale A.L. Role of amygdaloid nuclei in the anxiolytic effects of benzodiazepines in rats. Behav. Pharmacol. 3 (1992) 261-264
115. Guarraci F.A., Frohardt R.J., and Kapp B.S. Amygdaloid D1 dopamine receptor involvement in Pavlovian fear conditioning. Brain Res. 827 (1999) 28-40
116. Guarraci F.A., Frohardt R.J., Young S.L., and Kapp B.S. A functional role for dopamine transmission in the amygdala during conditioned fear. Ann. N.Y. Acad. Sci. 877 (1999) 732-736
117. Guarraci F.A., Frohardt R.J., Falls W.A., and Kapp B.S. The effects of intra-amygdaloid infusion of a D2 dopamine receptor antagonist on Pavlovian fear conditioning. Behav. Neurosci. 114 (2000) 647-651
118. Gurevich E.V., and Joyce J.N. Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons. Neuropsychopharmacology 20 (1999) 60-80
119. Hagelberg N., Martikainen I.K., Mansikka H., Hinkka S., Nagren K., Hietala J., Scheinin H., and Pertovaara A. Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity. Pain 99 (2002) 273-279
120. Hatfield T., Han J.-S., Conley M., Gallagher M., and Holland P. Neurotoxic lesions of basolateral but not central amygdala interfere with Pavlovian second-order conditioning and reinforce devaluation effects. J. Neurosci. 16 (1996) 5256-5265
121. 3H] 7-hydroxy-N,N-di-n-propyl-2-aminotetralin. Brain Res. 648 (1994) 222-228
122. Hitchkott P.K., and Phillips J.D. Double dissociation of the behavioural effects of R(+) 7-OH-DPAT infusions in the central and basolateral amygdala nuclei upon Pavlovian and instrumental conditioned appetitive behaviours. Psychopharmacology 140 (1998) 458-469
123. Hökfelt, T., Martensson, R., Bjorklund, A., Kleinau, S., Goldstein, M., 1984. Distribution maps of tyrosine-hydroxylase-immunoreactivity neurons in the rat brain. Classic transmitters in the CNS. In: Björklund, A., Lindvall, O. (Eds.), Handbook of Chemical Neuroanatomy. Elsevier, Amsterdam, pp. 277-386.
124. Holland P.C., and Gallagher S. Amygdala central nucleus lesions disrupt increments, but not decrements in conditioned stimulus processing. Behav. Neurosci. 107 (1993) 246-253
125. Holland P.C., and Gallagher S. Amygdala circuitry in attentional and representational processes. Trends Cognit. Sci. 3 (1999) 65-73
126. Holland P.C., and Gallager M. Double dissociation of the effects of lesions of basolateral and central amygdala on conditioned stimulus-potentiated feeding and Pavlovian-instrumental transfer. Eur. J. Neurosci. 17 (2003) 1680-1694
127. Holland P.C., Hatfield T., and Gallagher M. Rats with basolateral amygdala lesions show normal increases in conditioned stimulus processing but reduced conditioned potentiating of eating. Behav. Neurosci. 115 (2001) 945-950
128. Hori K., Tanaka J., and Nomura M. Effects of discrimination learning on the rat amygdala dopamine release: a microdialysis study. Brain Res. 621 (1993) 296-300
129. Huang Y.Y., and Kandel E.R. Postsynaptic induction and PKA-dependent expression of LTP in the lateral amygdala. Neuron 21 (1998) 169-178
130. Huang Q., Zhou D., Chase K., Gusella J.F., Aronin N., and DiFiglia M. Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 11988-11992
131. Hyttel J. SCH 23390-the first selective dopamine D-1 antagonist. Eur. J. Pharmacol. 91 (1983) 153-154
132. Inglis F.M., and Moghaddam B. Dopaminergic innervation of the amygdala is highly responsive to stress. J. Neurochem. 72 (1999) 1088-1094
133. Jin L.Q., Wang H.Y., and Friedman E. Stimulated D(1) dopamine receptors couple to multiple Galpha proteins in different brain regions. J. Neurochem. 78 (2001) 981-990
134. Johnston J.B. Further contributions to the study of the evolution of the forebrain. J. Comp. Neurol. 35 (1923) 337-481
135. Juhász M., Kobor G., Lajtha A., and Vadász C. Autoradiographic distribution of binding sites of [3H]SKF 38393, a selective dopamine D1 receptor agonist, in the mouse forebrain. Brain Res. 423 (1987) 305-308
136. Kaelber W.W., and Afifi A.K. Nigro-amygdaloid fiber connections in the cat. Am. J. Anat. 148 (1977) 129-135
137. Kandell E.R. Gene synapses and long term memory. J. Cell. Physiol. 173 (1997) 124-125
138. Karasinska J.M., George S.R., El-Ghundi M., Fletcher P.J., and O'Dowd B.F. Modification of dopamine D(1) receptor knockout phenotype in mice lacking both dopamine D(1) and D(3) receptors. Eur. J. Pharmacol. 399 (2000) 171-181
139. Keay K., and Bandler R. Parallel circuits mediating distinct emotional coping reactions to different types of stress. Neurosci. Biobehav. Rev. 25 (2001) 669-678
140. Kebabian J.W., and Calne D.B. Multiple receptors for dopamine. Nature 277 (1979) 93-96
141. Kessler R.M., Whetsell W.O., Ansari M.S., Votaw J.R., de Paulis T., Clanton J.A., Schmidt D.E., Mason N.S., and Manning R.G. Identification extrastriatal dopamine D2 receptors in post mortem human brain with [1251]epidepride. Brain Res. 609 (1993) 237-243
142. Killcross S., Robbins T.W., and Everitt B.J. Different types of fear conditioned behavior mediated by separate nuclei within amygdala. Nature 388 (1977) 377-380
143. Kilts C.D., Anderson C.M., Ely T.D., and Nishita J.D. Absence of synthesis-modulating nerve terminal autoreceptors on mesoamygdaloid and other mesolimbic dopamine neuronal populations. J. Neurosci. 7 (1987) 3061-3975
144. Kilts C.D., Anderson C.M., Ely T.D., and Mailman R.B. The biochemistry and pharmacology of mesoamygdaloid dopamine neurons. Ann. N.Y. Acad. Sci. 537 (1988) 173-187
145. Kling A., and Brothers L.A. The amygdala in social behavior. In: Agletton J.P. (Ed). The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction (1992), Wiley-Liss Inc., New York 353-377
146. Kluver H., and Bucy P.C. Psychic blindness and other symptoms following bilateral temporal lobectomy in rhesus monkeys. Am. J. Physiol. 119 (1937) 352-353
147. Kluver H., and Bucy P.C. Preliminary analysis of functions of the temporal lobes in monkeys. Arch. Neurol. Psychiatry 42 (1939) 979-1000
148. Krettek J.E., and Price J.L. A description of the amygdaloid complex in the rat and cat with observations on intra-amygdaloid axonal connections. J. Comp. Neurol. 178 (1978) 255-280
149. Krettek J.E., and Price J.L. Amygdaloid projections to subcortical structures within the basal forebrain and brain stem in the rat and cat. J. Comp. Neurol. 178 (1978) 225-254
150. Kröner S., Rosenkranz J.A., Grace A.A., and Barrionuevo G. Dopamine modulates excitability of basolateral amygdala neurons in vitro. J. Neurophysiol. 93 (2005) 1598-1610
151. Koolhaas J.M., Korte S.M., De Boer S.F., Van der Vegt B.J., Van Reenen C.G., Hopster H., De Jong I.C., Ruis M.A.W., and Blockhuis H.J. Coping styles in animals: current status in behavior and stress-physiology. Neurosci. Biobehav. Rev. 23 (1999) 925-935
152. Koolhaas J.M., De Boer S.F., Buwalda B., and Van Reenen K. Individual variation in coping with stress: a multidimensional approach of ultimate and proximate mechanisms. Brain Behav. Evol. 70 (2007) 216-226
153. Korte S.M., Bouws G.A.H., Koolhaas J.M., and Bohus B. Neuroendocrine and behavioral responses during conditioned active and passive behavior in the defensive burying/probe avoidance paradigm: effects of ipsapirone. Physiol. Behav. 52 (1992) 355-361
154. LaLumiere R.T., Nguyen L.T., and McGaugh J.L. Post-training intrabasolateral amygdala infusions of dopamine modulate consolidation of inhibitory avoidance memory: involvement of noradrenergic and cholinergic systems. Eur. J. Neurosci. 20 (2004) 2804-2810
155. Lamont E.W., and Kokkinidis L. Infusion of the dopamine D1 receptor antagonist SCH 23390 into the amygdala blocks fear expression in a potentiated startle paradigm. Brain Res. 795 (1998) 128-136
156. Lang E.J., and Paré D. Synaptic responsiveness of interneurons of the cat lateral amygdaloid nucleus. Neuroscience 83 (1998) 877-889
157. Leaton R.N., Cassella J.V., and Borszcz G.S. Short-term and long-term habituation of the acoustic startle response in chronic decerebrate rats. Behav. Neurosci. 99 (1985) 901-912
158. LeDoux J.E., Iwata J., Cicchetti P., and Reis D.J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J. Neurosci. 8 (1988) 2517-2529
159. LeDoux J.E., Cicchetti P., Xagoraris A., and Romanski L.M. The lateral amygdaloid nucleus: sensory interface of the amygdala in fear conditioning. J. Neurosci. 10 (1990) 1062-1069
160. LeDoux J.E., Farb C., and Ruggiero D.A. Topographic organization of neurons in the acoustic thalamus that project to the amygdala. J. Neurosci. 10 (1990) 1043-1054
161. LeDoux J.E. Emotion and the amygdala. In: Agletton J.P. (Ed). The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction (1992), Wiley-Liss Inc., New York 330-352
162. LeDoux J.E. Fear and the brain: Where have we been, and where are we going?. Soc. Biol. Psychiatry 44 (1998) 1229-1238
163. LeDoux J.E. Emotion circuits in the brain. Annu. Rev. Neurosci. 23 (2000) 155-184
164. Le Moal M., Cardo B., and Stinus L. Influence of ventral mesencephalic lesions on various spontaneous and conditioned behaviors. Physiol. Behav. 4 (1969) 567-574
165. Leonard S.K., Anderson C.M., Lachowicz J.E., Schulz D.W., Kilts C.D., and Mailman R.B. Amygdaloid D1 receptors are not linked to stimulation of adenylate cyclase. Synapse 50 (2003) 320-333
166. Lee F.J., Xue S., Pei L., Vukusic B., Chéry N., Wang Y., Wang Y.T., Niznik H.B., Yu X.M., and Liu F. Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Cell 111 (2002) 219-230
167. Levant B., Grigoriadis D.E., and DeSouza E.B. [3H] quinpirole binding to putative D2 and D3 dopamine receptors in rat brain pituitary gland: a quantitative autoradiographic study. J. Pharmacol. Exp. Ther. 264 (1993) 991-1001
168. Levey A.I., Hersch S.M., Rye D.B., Sunahara R.K., Niznik H.B., Kitt C.A., Price D.L., Maggio R., Brann M.R., and Ciliax B.J. Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 8861-8865
169. Likhtik E., Pelletier J.G., Paz R., and Paré D. Prefrontal control of the amygdala. J. Neurosci. 25 (2005) 7429-7437
170. Lindvall O., and Björklund A. The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method. Acta Physiol. Scand. Suppl. 412 (1974) 1-48
171. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92 (1987) 180-185
172. Lister R.G. Ethologically-based animal models of anxiety disorders. Pharmacol. Ther. 46 (1990) 321-340
173. López-Ruvalcaba C. Pre- or postsynaptic activity of 5-HT1A compounds in mice depends on the anxiety paradigm. Pharmacol. Biochem. Behav. 54 (1996) 677-768
174. Lorétan K., Bissière S., and Lüthi A. Dopaminergic modulation of spontaneous inhibitory network activity in the lateral amygdala. Neuropharmacology 47 (2004) 631-639
175. Low K., Crestani F., Keist R., Benke D., Brunig I., Benson J.A., Fritschy J.M., Rulicke T., Bluethmann H., Mohler, and Rudolph U. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290 (2000) 131-134
176. Málková L., Gaffan D., and Murray E.A. Excitotoxic lesions of the amygdala fails to produce impairment in visual learning for auditory secondary reinforcement but interfere with reinforcer devaluation effects in rhesus monkeys. J. Neurosci. 17 (1997) 6011-6020
177. Maltais S., Côté S., Drolet G., and Falardeau P. Cellular colocalization of dopamine D1 mRNA and D2 receptor in rat brain using a D2 dopamine receptor specific polyclonal antibody. Prog. Neuropsychopharmacol. Biol. Psychiatry 24 (2000) 1127-1149
178. Mansour A., Meador-Woodruff J.H., Bunzow J.R., Civelli O., Akil H., and Watson S.J. Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis. J. Neurosci. 10 (1990) 2587-2600
179. Mansour A., Meador-Woodruff J.H., Zhou Q.Y., Civelli O., Akil H., and Watson S.J. A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience 46 (1992) 959-971
180. Mansour A., and Watson Jr. S.J. Dopamine receptor expression in the central nervous system. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology IV Generation of Progress (1995), Raven Press, New York 207-219
181. Maren S. Long-term potentiation in the amygdala: a mechanism for emotional learning and memory. Trends Neurosci. 22 (1999) 561-567
182. Margolis E.B., Mitchell J.M., Ishikawa J., Hjlmstad J.O., and Fields H.L. Midbrain dopamine neurons: projection target determines axon potential duration and dopamine D(2) receptor inhibition. J. Neurosci. 28 (2008) 8908-8913
183. A receptor subtypes. Eur. J. Neurosci. 20 (2004) 1281-1289
184. Marowsky A., Yanagawa Y., Obata K., and Vogt K.E. A specialized subclass of interneurons mediates dopaminergic facilitation of amygdala function. Neuron 48 (2005) 1025-1037
185. Mayford M., and Kandell E.R. Genetic approaches to memory storage. Trends Genet. 15 (1999) 463-470
186. McDonald A.J. Cell types and intrinsic connections of the amygdala. In: Aggleton P.J. (Ed). The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction (1992), Wiley-Liss, Inc., New York 67-96
187. McDonald A.J. Glutamate and aspartate immunoreactive neurons of the rat basolateral amygdala: colocalization of excitatory amino acids and projections to the limbic circuit. J. Comp. Neurol. 365 (1996) 367-379
188. McDonald A.J. Cortical pathways to the mammalian amygdala. Prog. Neurobiol. 55 (1998) 257-332
189. McDonald A.J. Is there an amygdala and how far does it extend? An anatomical perspective. Ann. N.Y. Acad. Sci. 985 (2003) 1-21
190. McDonald A.J., and Augustine J.R. Localization of GABA-like immunoreactivity in the monkey amygdala. Neuroscience 52 (1993) 281-294
191. McDonald A.J., Mascagni F., and Guo L. Projections of the medial and lateral prefrontal cortices to the amygdala: a Phaseolus vulgaris leucoaglutinin study in the rat. Neuroscience 71 (1996) 55-75
192. McGaugh J.L., Introini-Collison I.B., Cahill R., Kim M., and Liang K. Involvement of the amygdala in neuromodulatory influences on memory storage. In: Aggleton P.J. (Ed). The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction (1992), Wiley-Liss, Inc., New York 431-451
193. McNaughton N., and Corr P.J. A two-dimensional neuropsychology of defense: fear/anxiety and defensive distance. Neurosci. Biobehav. Rev. 28 (2004) 285-305
194. Meador-Woodruff J.H., Mansour A., Healy D.J., Kuehn R., Zhou Q.Y., Bunzow J.R., Akil H., Civelli O., and Watson Jr. S.J. Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain. Neuropsychopharmacology 5 (1991) 231-242
195. Meador-Woodruff J.H., Mansour A., Civelli O., and Watson S.J. Distribution of D2 dopamine receptor mRNA in the primate brain. Prog. Neuropsychopharmacol. Biol. Psychiatry 15 (1991) 885-893
196. Menard J., and Treit D. Effects of centrally administered anxiolytic compounds in animal models of anxiety. Neurosci. Biobehav. Rev. 23 (1999) 591-613
197. Menard J., and Treit D. The anxiolytic effects of intra-hippocampal midazolam are antagonized by intra-septal L-glutamate. Brain Res. 888 (2001) 163-166
198. Mengod G., Vilaró M.T., Niznik H.B., Sunahara R.K., Seeman P., O'Dowd B.F., and Palacios J.M. Visualization of a dopamine D1 receptor mRNA in human and rat brain. Brain Res. Mol. 10 (1991) 185-191
199. Millan M.J., Dekeyne A., Rivet J.M., Dubuffet T., Lavielle G., and Brocco M. S33084, a novel, potent, selective, and competitive antagonist at dopamine D3 receptors. II. Functional and behavioral profile compared with GR218231 and L741626. J. Pharmacol. Exp. Ther. 293 (2000) 1063-1073
200. Millan M.J. The neurobiology and control of anxious states. Prog. Neurobiol. 70 (2003) 83-244
201. Millhouse O.E. The intercalated cells of the amygdala. J. Comp. Neurol. 247 (1986) 246-271
202. Missale C., Nash S.R., Robinson S.W., Jaber M., and Caron M.C. Dopamine receptors: from structure to function. Physiol. Rev. 78 (1998) 189-225
203. Mukherjee J., Christian B.T., Dunigan K.A., Shi B., Narayanan T.K., Satter M., and Mantil J. Brain imaging of 18F-fallpride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D2/D-3 receptors. Synapse 46 (2002) 170-188
204. Muller J.F., Mascagni F., and McDonald A.J. Dopaminergic innervation of pyramidal cells in the rat basolateral amygdala. Brain Struct. Funct. 213 (2009) 275-278
205. Munro L.J., and Kokkinidis L. Infusion of quinpirole and muscimol into the ventral tegmental area inhibits fear-potentiated startle: implications for the role of dopamine in fear expression. Brain Res. 746 (1997) 231-238
206. Murray A.M., Ryhoo H.L., Gurevich E., and Joyce J.N. Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 11271-11275
207. Nader K., and LeDoux J.E. Inhibition of the mesoamygdala dopaminergic pathway impairs the retrieval of conditioned fear associations. Behav. Neurosci. 113 (1999) 891-901
208. Nauta W.J.H. Neural associations of the amygdaloid complex in the monkey. Brain 85 (1962) 505-520
209. Neugebauer V., Galhardo V., Maione S., and Mackey S.C. Forebrain pain mechanisms. Brain Res. Rev. 60 (2009) 226-242
210. Neve K.A., Seamans J.K., and Trantham-Davidson H. Dopamine receptor signalling. J. Recept. Signal Transduct. Res. 24 (2004) 165-205
211. Nissbrandt H., Ekman A., Eriksson E., and Heilig M. Dopamine D3 receptor antisense influences dopamine synthesis in the rat brain. NeuroReport 6 (1995) 573-576
212. Nitecka L., and Ben-Ari Y. Distribution of GABA-like immunoreactivity in the rat amygdaloid complex. J. Comp. Neurol. 266 (1987) 45-55
213. Okubo Y., Olsson H., Ito H., Lofti M., Suhara T., Halldin C., and Farde L. PET mapping extratriatal D2-like dopamine receptors in the human brain using an anatomic standardization technique and 11C FLB 457. Neuroimage 10 (1999) 666-674
214. Onali P.L., Olianas M.C., and Gessa G.L. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in the rat striatum. Mol. Pharmacol. 28 (1985) 138-145
215. Palacios J.M., Camps M., Cortés R., and Probst A. Mapping dopamine receptors in the human brain. J. Neural Transm. Suppl. 27 (1988) 227-235
216. Paré D., and Smith Y. Distribution of GABA immunoreactivity in the amygdaloid complex of the cat. Neuroscience 57 (1993) 1061-1076
217. Paré D., Quirk G.J., and LeDoux J.E. New vistas on amygdala networks in conditioned fear. J. Neurophysiol. 92 (2004) 1-9
218. Pérez de la Mora M., Ferré S., and Fuxe K. GABA-dopamine receptor-receptor interactions in neostriatal membranes of the rat. Neurochem. Res. 22 (1997) 1051-1054
219. Pérez de la Mora M., Cárdenas-Cachón L., Vázquez-García M., Crespo-Ramírez M., Jacobsen K., Höistad M., Agnati L., and Fuxe K. Anxiolytic effects of intra-amygdaloid injection of the D1 antagonist SCH23390 in the rat. Neurosci. Lett. 377 (2005) 101-105
220. Pérez de la Mora M., Lara-García D., Jacobsen K.X., Vázquez-García M., Crespo-Ramírez M., Flores-Gracia C., Escamilla-Marvan E., and Fuxe K. Anxiolytic-like effects of the selective metabotropic glutamate receptor 5 antagonist MPEP after its intra-amygdaloid microinjection in three different non-conditioned rat models of anxiety. Eur. J. Neurosci. 23 (2006) 2749-2759
221. Pérez de la Mora M., Hernández-Gómez A.M., Arizmendi-García Y., Jacobsen K.X., Lara-García D., Flores-Gracia C., Crespo-Ramírez M., Gallegos-Cari A., Nuche-Bricaire A., and Fuxe K. Role of the amygdaloid cholecystokinin (CCK)/gastrin-2 receptors and terminal networks in the modulation of anxiety in the rat. Effects of CCK-4 and CCK-8S on anxiety-like behaviour and [3H]GABA release. Eur. J. Neurosci. 26 (2007) 3614-3630
222. Pérez de la Mora M., Jacobsen K.H., Crespo-Ramírez M., Flores-Gracia C., and Fuxe K. Wiring and volume transmission in rat amygdala. Implications for fear and anxiety. Neurochem. Res. 33 (2008) 1618-1633
223. Parkinson J.A., Cardinal R.N., and Everitt B.J. Limbic cortical-ventral striatal systems underlying appetitive conditioning. Prog. Brain Res. 126 (2000) 263-285
224. Parkinson J.A., Robbins T.W., and Everitt B.J. Dissociable roles of the central and basolateral amygdala in appetitive emotional learning. Eur. J. Neurosci. 12 (2000) 405-413
225. Pesold C., and Treit D. The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res. 671 (1995) 213-221
226. Petty F., Mott J., and Sherman A.D. Potential locus and mechanism of blockade of conditioned avoidance responding by neuroleptics. Neuropharmacology 23 (1984) 73-78
227. Pezze M.A., and Feldon J. Mesolimbic dopaminergic pathways in fear conditioning. Prog. Neurobiol. 74 (2004) 301-320
228. Pfeiffer F.R., Wilson J.W., Weinstock J., Kuo G.Y., Chambers P.A., Holden K.G., et al. Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines. J. Med. Chem. 25 (1982) 352-358
229. Phillips A.G., Ahn S., and Howland J.G. Amygdalar control of the mesocorticolimbic dopamine system: parallel pathways to motivated behavior. Neurosci. Biobehav. Rev. 27 (2003) 543-554
230. Pinard C.R., Muller J.F., Mascagni F., and McDonald A.J. Dopaminergic innervation of interneurons of the rat basolateral amygdala. Neuroscience 157 (2008) 850-863
231. Pinel P.J., and Treit D. Burying as a defense response in rats. J. Comp. Physiol. Psychol. 92 (1978) 708-712
232. Pinto A., and Sesack S.R. Ultrastructural analysis of prefrontal cortical inputs to the rat amygdala: spatial relationships to presumed dopamine axons and D1 and D2 receptors. Brain Struct. Funct. 213 (2008) 159-175
233. Pitkänen A., and Amaral D.G. The distribution of GABAergic cells, fibers, and terminals in the monkey amygdaloid complex: an immunohistochemical and in situ hybridization study. J. Neurosci. 14 (1994) 2200-2224
234. Pitkänen A., Stefanacci L., Farb C.R., Go G.G., LeDoux J.E., and Amaral D.G. Intrinsic connections of the rat amygdaloid complex: projections originating in the lateral nucleus. J. Comp. Neurol. 356 (1995) 288-310
235. Price J.L., and Amaral D.G. An autoradiographic study of the projections of the central nucleus of the monkey amygdala. J. Neurosci. 1 (1981) 1242-1259
236. Price J.L., Russchen F.T., and Amaral D.G. The limbic region. II. The amygdaloid complex. In: Björklund A., Hökfelt T., and Swanson L.W. (Eds). Handbook of Chemical Neuroanatomy, vol. 5. Integrated Systems of the CNS (1987), Elsevier, Amsterdam 279-381
237. Quirk G.J., Repa C., and LeDoux J.E. Fear conditioning enhances short-latency auditory responses of lateral amygdala neurons: parallel recordings in the freely behaving rat. Neuron 15 (1995) 1029-1039
238. Quirk G.J., Armony J.L., and LeDoux J.E. Fear conditioning enhances different temporal components of tone-evoked spike trains in auditory cortex and lateral amygdala. Neuron 19 (1997) 613-624
239. Quirk G.J., Likhtik E., Pelletier J.G., and Paré D. Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons. J. Neurosci. 23 (2003) 8800-8807
240. Radnikow G., and Misgeld U. Dopamine D1 receptors facilitate GABAA synaptic currents in the rat substantia nigra pars reticulata. J. Neurosci. 18 (1998) 2009-2016
241. Ramos A., Berton O., Mormède P., and Chauloff F. A multiple-test study of anxiety-related behaviors in six inbred rat strains. Behav. Brain Res. 85 (1997) 57-69
242. Reis F.L., Masson S., Oliveira A.R., and Brandão M.L. Dopaminergic mechanisms in the conditioned and unconditioned fear as assessed by the two-way avoidance and light switch-off tests. Pharmacol. Biochem. Behav. 79 (2004) 359-365
243. Ressler K.J., and Mayberg H.S. Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat. Neurosci. 10 (2007) 1116-1124
244. Rivet J.-M., Audinot V., Gobert A., Peglion J.-L., and Millan M.J. Modulation of mesolimbic dopamine release by selective dopamine D3 receptor antagonist, (+) S 14297. Eur. J. Pharmacol. 265 (1994) 175-177
245. Robledo P., Robbins T.W., and Everitt B.J. Effects of excitotoxic lesions of the central amygdaloid nucleus on the potentiation of reward-related stimuli by intra-accumbens amphetamine. Behav. Neurosci. 110 (1996) 981-990
246. Rodgers R.J. Animal models of 'anxiety': where next?. Behav. Pharmacol. 8 (1997) 477-496
247. Rodgers R.J., Nikulina E.M., and Cole J.C. Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze. Pharmacol. Biochem. Behav. 49 (1994) 985-995
248. Rogan M.T., Staubli U.V., and LeDoux J.E. Fear conditioning induces associative long-term potentiation in the amygdala. Nature 390 (1997) 604-607
249. Romanski L.M., and LeDoux J.E. Equipotentiality of thalamo-amygdala and thalamo-cortico-amygdala circuits in auditory fear conditioning. J. Neurosci. 12 (1993) 4501-4509
250. Rosenkranz J.A., and Grace A.A. Modulation of basolateral amygdala neuronal firing and afferent drive by dopamine receptor activation in vivo. J. Neurosci. 19 (1999) 11027-11039
251. Rosenkranz J.A., and Grace A.A. Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats. J. Neurosci. 21 (2001) 4090-4103
252. Rosenkranz J.A., and Grace A.A. Cellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo. J. Neurosci. 22 (2002) 324-337
253. Rosenkranz J.A., and Grace A.A. Dopamine-mediated modulation of odour-evoked amygdala potentials during Pavlovian conditioning. Nature 417 (2002) 282-287
254. Rosenkranz J.A., Buffalari D.M., and Grace A.A. Opposing influences of basolateral amygdala and footshock stimulation on neurons of the central amygdala. Biol. Psychiatry 59 (2006) 801-811
255. Roth R.H., Wulf M.E., and Deutch A.Y. Neurochemistry of midbrain dopamine systems. In: Meltzer H.Y. (Ed). Psychopharmacology: The third Generation of Progress (1987), Raven Press, New York 81-94
256. Royer S., Martina M., and Paré D. An inhibitory interface gates impulse traffic between the input and output stations of the amygdala. J. Neurosci. 19 (1999) 10575-10583
257. Royer S., Martina M., and Paré D. Polarized synaptic interactions between intercalated neurons of the amygdala. J. Neurophysiol. 83 (2000) 3509-3518
258. Royer S., and Paré D. Bidirectional synaptic plasticity in intercalated amygdala neurons and the extinction of conditioned fear responses. Neuroscience 115 (2002) 455-462
259. Sadikot A.F., and Parent A. The monoaminergic innervation of the amygdala in the squirrel monkey: an immunohistochemical study. Neuroscience 36 (1990) 431-447
260. Sandbak T., and Murison R. Behavioral responses to elevated plus-maze and defensive burying testing: effects on subsequent ethanol intake and effect of ethanol on retention of the burying response. Alcohol Alcohol. 36 (2001) 48-58
261. Schulz D.W., Stanford E.J., Wyrick S.W., and Mailman R.B. Binding of [3H] SCH23390 in rat brain: regional distribution and effects of assay conditions and GTP suggest interactions at a D1-like dopamine receptor. J. Neurochem. 45 (1985) 1601-1611
262. Scibilia R.J., Lachowicz J.E., and Kilts C.D. Topographic nonoverlapping distribution of D1 and D2 dopamine receptors in the amygdaloid nuclear complex of the rat brain. Synapse 11 (1992) 146-154
263. Selden N.R., Everitt B.J., Jarrard L.E., and Robbins T.W. Complementary roles for the amygdala and hippocampus in aversive conditioning to explicit and contextual cues. Neuroscience 42 (1991) 335-350
264. Sherman A.D., Petty F., and Sacquitne J.L. Regional aspects of the delay of acquisition conditioned avoidance responding by chlorpromazine. Life Sci. 30 (1982) 1811-1815
265. Shi C., and Davis M. Pain pathways involved in fear conditioning measured with fear-potentiated startle: lesion studies. J. Neurosci. 19 (1999) 420-430
266. Short J.L., Ledent C., Drago J., and Lawrence A.J. Receptor crosstalk: characterization of mice deficient in dopamine D1 and adenosine A2A receptors. Neuropsychopharmacology 31 (2006) 525-534
267. 3H]leucine and horseradish peroxidase. Brain Res. 178 (1979) 17-40
268. Singewald N., and Sharp T. Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry. Neuroscience 98 (2000) 759-770
269. Smith Y., and Paré D. Intra-amygdaloid projections of the lateral nucleus in the cat: PHA-L anterograde labeling combined with postembedding GABA and glutamate immunocytochemistry. J. Comp. Neurol. 342 (1994) 232-248
270. Sokoloff P., Giros B., Martres M.P., Barthenet M.L., and Schwartz J.C. Molecular cloning and characterization of a novel dopamine receptor (D-3) as a target for neuroleptics. Nature 347 (1990) 146-151
271. Sokoloff P., and Schwartz J.C. Novel dopamine receptors half a decade later. Trends Pharmacol. Sci. 16 (1995) 270-275
272. Sun N., and Cassel M.D. Intrinsic GABAergic neurons in the rat central amygdala. J. Comp. Neurol. 330 (1993) 381-404
273. Sun N., Yi H., and Cassell M.D. Evidence for a GABAergic interface between cortical afferents and brainstem projection neurons in the rat central extended amygdala. J. Comp. Neurol. 340 (1994) 43-64
274. Suzuki M., Hurd Y.L., Sokoloff P., Schwartz J.C., and Sedvall G. D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res. 779 (1998) 58-74
275. Swanson L.W. The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res. Bull. 9 (1982) 321-353
276. Swanson L.W., and Petrovich G.D. What is the amygdala?. Trends Neurosci. 21 (1998) 323-331
277. Talalaenko A.N., Abramets I.A., Stakhovskii Yu.V., Shekhovtsov A.A., Chernikov A.V., and Shevchenko S.L. The role of dopaminergic mechanisms on the brain in various models of anxious states. Neurosci. Behav. Physiol. 24 (1994) 284-288
278. Taylor B.K., Joshi C., and Uppal H. Stimulation of dopamine D2 receptors in the nucleus accumbens inhibits inflammatory pain. Brain Res. 987 (2003) 135-143
279. Thierry A.M., Stinus L., Blanc G., and Glowinski J. Some evidence for the existence of dopaminergic neurons in the rat cortex. Brain Res. 50 (1973) 230-234
280. Timothy C., Costall B., and Smythe J.W. Effects of SCH 23390 and raclopride on anxiety-like behavior in rats tested in the black-white box. Pharmacol. Biochem. Behav. 62 (1999) 323-327
281. Treit D., Pesold C., and Rotzinger S. Dissociating the anti-fear effects of septal and amygdaloid lesions using two pharmacologically validated models of rats anxiety. Behav. Neurosci. 107 (1993) 770-785
282. Treit D., Robinson A., Rotzinger S., and Pesold C. Anxiolytic effects of serotonergic interventions in the shock-probe burying test and the elevated plus-maze test. Behav. Brain Res. 54 (1993) 23-34
283. Treit D., Menard J., and Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol. Biochem. Behav. 44 (1993) 463-469
284. Treit D., and Menard J. Dissociations among the anxiolytic effects of septal, hippocampal and amygdaloid lesions. Behav. Neurosci. 111 (1997) 653-658
285. Undie A.S., and Friedman E. Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain. J. Pharmacol. Exp. Ther. 253 (1990) 987-992
286. Ungerstedt U. Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol. Scand., Suppl. 367 (1971) 1-48
287. Van Tol H.H.M., Bunzow J.R., Guan H.C., Sunahara R.K., Seeman P., Niznik H.B., and Civelli O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350 (1991) 610-614
288. Vazdarjanova A., and McGaugh J.L. Basolateral amygdala is not critical for cognitive memory of contextual fear conditioning. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 15003-15007
289. Vazdarjanova A., Cahill L., and McGaugh J.L. Disrupting basolateral amygdala function impairs unconditioned freezing and avoidance in rats. Eur. J. Pharmacol. 14 (2001) 709-718
290. Wall P.M., and Messier C. Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior. Neurosci. Biobehav. Rev. 25 (2001) 275-286
291. Wamsley J.K., Gehlert D.R., Filloux F.M., and Dawson T.M. Comparison of the distribution of D1 and D2 dopamine receptors in the rat brain. J. Chem. Neuroanat. 2 (1989) 119-137
292. Weiner D.M., Levey A.I., Sunahara R.K., Niznik H.B., O'Dowd B.F., Seeman P., and Brann M.R. D1 and D2 dopamine receptor mRNA in rat brain. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 1859-1863
293. Weiskrantz L. Behavioral changes associated with ablation of the amygdaloid complex in monkeys. J. Comp. Physiol. Psychol. 4 (1956) 381-391
294. Wood P.B. Mesolimbic dopaminergic mechanisms and pain control. Pain 120 (2006) 230-234
295. Xiang L., Szebeni K., Klimek V., Stockmeir C.A., Karolewiez B., Kalbfleisch J., and Ordway G.A. Dopamine receptor gene expression in human amygdaloid nuclei: elevated D4 receptor mRNA in major depression. Brain Res. 1207 (2008) 214-224
296. Yokoyama M., Suzuki E., Sato T., Maruta S., Watanabe S., and Miyaoka H. Amygdalic levels of dopamine and serotonin rise upon exposure to conditioned fear stress without elevation of glutamate. Neurosci. Lett. 379 (2005) 37-41
297. Young A.M., and Rees K.R. Dopamine release in the amygdaloid complex of the rat, studied by brain microdialysis. Neurosci. Lett. 249 (1998) 49-52
298. Zangrossi Jr. H., and File S.E. Behavioral consequences in animal tests of anxiety and exploration of exposure to cat odor. Brain Res. Bull. 29 (1992) 381-388